HOME         WEBSITE         SUBSCRIBE           E-GREETINGS   
                               

Friday, March 29, 2013

Irda wants you to focus on health, worry less about claims

Arbitrary premium hikes and claim processing delays could soon be a thing of past, with the Insurance Regulatory and Development Authority (Irda) finalising norms on health Insurance to address these issues. These directives, which will come into effect from October 1, are expected to change many practices in the health insurance space. 

Some of the guidelines, like mandatory lifetime renewal and minimum entry age limit of 65 years, are already in place. However, a few new ones like prohibiting insurers from hiking renewal premiums simply because of a claim made in the previous year will definitely help many policyholders. Claim-based loading — an industry practice where renewal premiums are hiked when you make claims — is often a cause of heartburn for policyholders.

After October 1, insurers will not be allowed to load premiums arbitrarily — they will have to base it on preceding three years’ claims experience as also expected claims experience. The reasoning behind proposed pricing will have to be justified. "Loading will apply only when individual claims experience for three consecutive years is 500% of current year premium. So, the insurance company can apply loading only, if say, the current year premium is . 15,000 and claims for three consecutive years amount to over . 75,000," explains Mahavir Chopra, head of personal lines and e-business with health insurance consultancy firm medimanage.

Also, you will be informed about any change in premium or renewal terms three months in advance. "The ’Delayed claim settlement to attract interest’ clause will have to be added to policy document. Also, insurers cannot reject claims without a proper medical reason," says activist Gaurang Damani, who had filed a petition in the Bombay High Court that led to Irda to formulating health insurance guidelines. Policyholders exasperated with third party administrators’ functioning can also expect some relief.

The insurance company, and not the TPA, will now have to take on the responsibility of settling or rejecting the claim. "TPA cannot settle claims, but only process claim. This will have a great impact, as only insurance companies can settle claims now. In cases where third-party administrators (TPA) issued cheques for claims, often, payments used to get delayed. Also, it was difficult to ascertain whether the TPA had handed over the entire claim amount approved by the insurer to the policyholder," says Damani.

This apart, the regulator has also sought to standardise definitions of certain terms, critical illnesses and exclusion among other things. "Policyholders will surely benefit due to the reduction in ambiguity of the various terms used by the different insurers leading to fewer disputes between them and the insurers. It also educates customers and reduces chances of their being taken for a ride by unscrupulous health care providers ," says Amarnath Ananthanarayan , CEO & MD, Bharti-AXA General Insurance.

Standardisation of norms
Given the voluminous policy documents and complicated language that policyholders have to deal with, it is hardly surprising that very few go through them. Besides, due to the ambiguity , clauses are open to interpretation , resulting in disputes. Therefore , Irda has come up with standard definitions for certain terms. "The standard definition has been prescribed for the 45 most common terms used in health insurance — such as day care treatment, hospital, inpatient care, pre-existing disease etc — that will help in reducing different interpretation by various stakeholders ," says Antony Jacob, CEO, Apollo Munich.

Henceforth, all insurers will have to stick to these definitions in their policy documents. Irda has also defined 11 critical illnesses that are covered under various policies. "Defining critical illnesses will reduce disappointment at the claims stage on the coverage norms and exclusions under each critical illness. This should certainly avoid confusion among consumers and industry," says Ramesh Ramani, senior vice-president , consumer lines, Tata-AIG General.

Common list of exclusions
As one of the chief causes for disputes is exclusions, the insurance regulator has finalised a list of expenses the insurance companies need not pay for. "The standardisation will reduce the disputes between the customers and the industry companies with respect to what is covered under an insurance policy, and therefore, payable as a claim," says Ananthanarayan. Irda has put out a list of 199 items and has indicated whether they are admissible or not. "The interpretation of the excluded items has been different at every stage by every stakeholder . Standardising the interpretation will ensure clarity. Policy coverage hasn’t been defined and has been left to the insurers. If the insurers wish to include these as part of the hospitalisation expenses in their product design , they are free to do so," adds Ramani.

Uniform claim forms
Yet another step towards eliminating confusion, this measure could come to the aid of policyholders at the most critical stage — at the time of making claims. "Standard pre-authorisation (for cashless claims) and claim form will significantly streamline processes at every stage. By implementing it in an optical character recognition (OCR) format, the ability to transfer data from a handwritten paper-based form to IT systems has been enhanced , thus reducing data entry issues for TPAs and insurers. This will help in reducing the turnaround time and hence result in swifter claim settlements," says Jacob. 


source: ET

Blog Archive

____________________________________________________________________________________________

Disclaimer - All investments in Mutual Funds and securities are subject to market risks and uncertainty of dividend distributions and the NAV of schemes may go up or down depending upon factors and forces affecting securities markets generally. The past performance of the schemes is not necessarily indicative of the future performance and may not necessarily provide a basis for comparison with other investments. Investors are advised to go through the respective offer documents before making any investment decisions. Prospective client(s) are advised to go through all comparable products in offer before taking any investment decisions. Mutual Funds and securities investments are subject to market risks and there is no assurance or guarantee that the objectives of the fund will be achieved. Information gathered & material used in this document is believed to be from reliable sources. Decisions based on the information provided on this newsletter/document are for your own account and risk.


In the preparation of the material contained in this document, Varun Vaid has used information that is publicly available, including information developed in-house. Some of the material used in the document may have been obtained from members/persons other than the Varun Vaid and which may have been made available to Varun Vaid. Information gathered & material used in this document is believed to be from reliable sources. Varun Vaid however does not warrant the accuracy, reasonableness and/or completeness of any information. For data reference to any third party in this material no such party will assume any liability for the same. Varun Vaid does not in any way through this material solicit any offer for purchase, sale or any financial transaction/commodities/products of any financial instrument dealt in this material. All recipients of this material should before dealing and or transacting in any of the products referred to in this material make their own investigation, seek appropriate professional advice.


Varun Vaid, shall not liable for any loss, damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising from the use of this material in any manner. The recipient alone shall be fully responsible/are liable for any decision taken on the basis of this material. All recipients of this material should before dealing and/or transacting in any of the products referred to in this material make their own investigation, seek appropriate professional advice. The investments discussed in this material may not be suitable for all investors. Any person subscribing to or investigating in any product/financial instruments should do soon the basis of and after verifying the terms attached to such product/financial instrument. Financial products and instruments are subject to market risks and yields may fluctuate depending on various factors affecting capital/debt markets. Please note that past performance of the financial products and instruments does not necessarily indicate the future prospects and performance there of. Such past performance may or may not be sustained in future. Varun Vaid, including persons involved in the preparation or issuance of this material may; (a) from time to time, have long or short positions in, and buy or sell the securities mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation in the financial instruments/products/commodities discussed here in or act as advisor or lender / borrower in respect of such securities/financial instruments/products/commodities or have other potential conflict of interest with respect to any recommendation and related information and opinions. The said person may have acted upon and/or in a manner contradictory with the information contained here. No part of this material may be duplicated in whole or in part in any form and or redistributed without the prior written consent of Varun Vaid. This material is strictly confidential to the recipient and should not be reproduced or disseminated to anyone else.


Varun Vaid also does not take any responsibility for the contents of the advertisements published. Readers are advised to verify the contents on their own before acting there upon.


Published Credits goes to following sources & all the mentioned sources as footer below the published material- Bloomberg, Valueresearch Online, Capital Market, Navindia, Franklin Templeton, Kitco, SBI AMC, LIC AMC, JM Financial AMC, HDFC AMC, The Hindu, Business Line, Personal FN, Economic Times, Reuters, Outlook Money, Business Standard, Times of India etc.